Latest updates and announcements
Our Perturb-seq platform has been updated with improved library construction protocols and expanded cell type support, enabling higher throughput and more reliable functional genomic screening results.
A new series of focused sgRNA libraries for immune checkpoint and synthetic lethality screening are now available, covering over 500 target genes with optimized design algorithms.
We are collaborating with research teams on generating high-quality genotype-phenotype association datasets for predictive cell modeling.
Our bioinformatics pipeline now supports integrated multi-omics analysis, combining CRISPR screen hits with transcriptomic and proteomic data for deeper biological insights.
Expanded cell line engineering capabilities now include knock-in services for difficult-to-transfect cell types, with verified on-target integration rates above 80%.
Our research team co-authored a landmark study published in Nature Methods, demonstrating scalable functional genomic screening across 50 cancer cell lines.
New sample preparation protocols reduce hands-on time by 40% while maintaining data quality, making single-cell experiments more accessible for routine research.
We have entered a strategic partnership with a top-10 pharma company to accelerate drug target discovery using our CRISPR screening platform.
Our Q3 catalog update includes 12 new gene editing kits for stem cell applications, with validated efficiency data across multiple iPSC lines.
No articles found in this category.
扫码咨询销售